You are here

China

AstraZeneca earns another approval in jam-packed Chinese PD-(L)1 market, this time in late-stage lung cancer

Endpoints

Mon, 07/19/21 - 11:05 am

A Chinese I/O biotech looking to turn around an old Novartis program gets a new fundraise after launching PhIII study

Endpoints

Thu, 07/15/21 - 10:46 am

immuno-oncology Adlai Nortye

Biogen builds MS pipeline via $125m deal with China’s InnoCare

Pharmaforum

Tue, 07/13/21 - 10:39 am

multiple sclerosis

BeiGene dives in on natural killer cells with discovery pact for small biotech's stem cell-based platform

Endpoints

Wed, 06/9/21 - 11:09 am

natural killer cells

Shoreline Biosciences

FDA review of Lilly/Innovent’s sintilimab paves way for cut-price immunotherapy option

Pharmaforum

Wed, 05/19/21 - 10:26 am

Landos Biopharma teams up with LianBio for $218M-plus collab and sales deal for 2 immunology assets in Asia

Fierce Biotech

Mon, 05/17/21 - 10:44 am

Landos Biopharma

ulcerative colitis

Crohn's Disease

U.S. wants COVID vaccine patent waiver to benefit world, not boost China biotech

Yahoo/Reuters

Sun, 05/9/21 - 11:01 pm

intellectual property

Sanofi reports sales growth amid Dupixent's China launch, but reveals PDUFA delay in Pompe disease program

Endpoints

Wed, 04/28/21 - 10:30 am

Nearing a COVID-19 vaccine approval in China, Fosun gears up to launch BioNTech shot: report

Fierce Pharma

Thu, 04/22/21 - 11:35 pm

Fosun Pharmaceutical

Chime Bio, flush with $190M, blueprints major biomanufacturing boost in China

Fierce Pharma

Tue, 04/6/21 - 10:30 am

drug manufacturing

Pfizer halts biosimilar programs in crowded China market, sells plant to WuXi Biologics

Fierce Pharma

Wed, 03/17/21 - 11:39 pm

Bristol Myers offloading Swiss tablet and capsule plant to Chinese CDMO WuXi STA

Fierce Pharma

Tue, 02/2/21 - 11:15 pm

Bristol-Myers Squibb

ISTA Pharmaceuticals

Illumina Partners with Sequoia Capital for its 3rd Life Science Incubator, This One in China

BioSpace

Tue, 02/2/21 - 11:07 pm

Sinopharm claims COVID-19 vaccine safe in kids aged 3 and up

Fierce Biotech

Fri, 01/15/21 - 09:43 am

Fast-expanding Shanghai Pharma breaks ground on $1.8B biotech park focused on next-gen R&D, antibody production

Endpoints

Mon, 01/4/21 - 10:23 am

Shanghai Pharmaceutical

Could a lymphoma drug work better against COVID-19 than Gilead's remdesivir?

Fierce Biotech

Sun, 01/3/21 - 04:29 pm

Gilead Sciences

Acrotech Biopharma

China’s Sinopharm Claims COVID-19 Vaccine has 79% Efficacy

BioSpace

Sun, 01/3/21 - 04:16 pm

clinical trials

Merck, Bristol Myers, AstraZeneca and Roche lose bid to expand PD-1/L1 reach in China

Fierce Pharma

Wed, 12/30/20 - 10:53 am

Bristol-Myers Squibb

PD-1 inhibitors

Allogene, broadening its reach, helps start a new biotech in China

BioPharma Dive

Tue, 12/15/20 - 10:47 am

Overland Pharmaceuticals

Allogene Overland Pharma

BioNTech, Fosun start COVID-19 vaccine trial to support Chinese approval

Fierce Biotech

Wed, 11/25/20 - 10:31 am

Fosun Pharmaceutical

clinical trials

Pages